Arrowpoint Advisory's Healthcare sector team has advised the shareholders of Spiegelberg (GmbH & Co.) KG on the sale of the business to investor group SHS GmbH.
Spiegelberg is a leading medical devices manufacturer based in Hamburg, Germany. Founded in 1986 by Dr. Andreas Spiegelberg, the company develops and supplies medical equipment for the monitoring of intracranial pressure, which is distributed in over 40 countries.
SHS is a specialist Healthcare and Life Sciences sector investor managing a €120m growth capital fund.
Close collaboration between the Arrowpoint Advisory teams in London and Dusseldorf brought this deal to a successful conclusion. Graham Carberry, Director at Arrowpoint Advisory commented: “This is an example of our cross-border capability. Dr Spiegelberg was introduced to the London team by a previous client in the sector, but having the Arrowpoint Advisory team on the ground in Germany was critical to delivering such a great result.”
We strongly believe that with SHS we found the best possible investor who will support the future internationalisation strategy of the company and at the same time agreed upon favourable and fair contractual terms with the sellers and management, which will stay with the company post closing.”
Closely following on from The GADA Group growth recapitalisation earlier this month, this deal further reinforces Arrowpoint Advisory's growing record in the medical devices space, having completed six transactions across Healthcare sector in 2011 so far.